Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Hopper

Showing results (301-310 of 894) with videos related to

Pageof 90
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2018
Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1Daniel D Buchanan, Jenna R Stewart, Mark Clendenning, et al.
Breast Cancer Research and Treatment|September 9, 2016
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumourEe Ming Wong, JiHoon E Joo, Catriona A McLean, et al.
Clinical Chemistry|January 12, 2012
Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot studyDavid E Godler, Howard R Slater, Quang M Bui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 yearsAmanda B Spurdle, John L Hopper, Xiaoqing Chen, et al.
BMC Medical Genomics|November 12, 2013
Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2Tú Nguyen-Dumont, Zhi L Teo, Bernard J Pope, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2023
Adherence to 2018 WCRF/AICR Cancer Prevention Recommendations and Risk of Cancer: The Melbourne Collaborative Cohort StudyYang Peng, Julie K Bassett, Allison M Hodge, et al.
Cancers|October 23, 2021
Prospective Evaluation over 15 Years of Six Breast Cancer Risk ModelsSherly X Li, Roger L Milne, Tú Nguyen-Dumont, et al.
Ophthalmology|February 25, 2014
Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort studyFakir M Amirul Islam, Elaine W Chong, Allison M Hodge, et al.
Human Pathology|August 24, 2014
Should the grading of colorectal adenocarcinoma include microsatellite instability status?Christophe Rosty, Elizabeth J Williamson, Mark Clendenning, et al.
Human Mutation|August 27, 2005
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancerJohn L Hopper, Vanessa M Hayes, Amanda B Spurdle, et al.
Pageof 90

Showing results (301-310 of 894) with videos related to

Sort By:
Pageof 90
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2018
Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1Daniel D Buchanan, Jenna R Stewart, Mark Clendenning, et al.
Breast Cancer Research and Treatment|September 9, 2016
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumourEe Ming Wong, JiHoon E Joo, Catriona A McLean, et al.
Clinical Chemistry|January 12, 2012
Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot studyDavid E Godler, Howard R Slater, Quang M Bui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 yearsAmanda B Spurdle, John L Hopper, Xiaoqing Chen, et al.
BMC Medical Genomics|November 12, 2013
Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2Tú Nguyen-Dumont, Zhi L Teo, Bernard J Pope, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2023
Adherence to 2018 WCRF/AICR Cancer Prevention Recommendations and Risk of Cancer: The Melbourne Collaborative Cohort StudyYang Peng, Julie K Bassett, Allison M Hodge, et al.
Cancers|October 23, 2021
Prospective Evaluation over 15 Years of Six Breast Cancer Risk ModelsSherly X Li, Roger L Milne, Tú Nguyen-Dumont, et al.
Ophthalmology|February 25, 2014
Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort studyFakir M Amirul Islam, Elaine W Chong, Allison M Hodge, et al.
Human Pathology|August 24, 2014
Should the grading of colorectal adenocarcinoma include microsatellite instability status?Christophe Rosty, Elizabeth J Williamson, Mark Clendenning, et al.
Human Mutation|August 27, 2005
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancerJohn L Hopper, Vanessa M Hayes, Amanda B Spurdle, et al.
Pageof 90